Home » Topics » BioWorld Science

BioWorld Science
RSS

Myrtelle enters licensing agreement with Rescue Hearing for gene therapy for genetic hearing loss

May 20, 2022

ORT-247 demonstrates efficacy in preclinical models of CMT and ALS

May 20, 2022

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

May 20, 2022

Preclinical studies of JAG-101, a gene therapy for type 1 galactosemia

May 20, 2022

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

May 20, 2022

Novel mouse models of RP59 retinal degeneration

May 20, 2022

Chulalongkorn University presents compounds for treating hepatitis B virus infections

May 20, 2022

Spectrum Pharmaceuticals divulges G12C mutant GTPase KRAS inhibitors

May 20, 2022

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

May 20, 2022

New CTP synthase 1 inhibitors discovered at Nimbus Clotho

May 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...